WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker as the Senate passed its legislation to deal with the opioid crisis:
Top News
Statement | September 17, 2018
Press Release | September 14, 2018
WASHINGTON, D.C. – AdvaMed Accel, the division of the Advanced Medical Technology Association (AdvaMed) focused on issues of concern to smaller medical technology companies, issued the following statement from Executive Director Ashley Wittorf on the introduction and markup this week of The American Innovation Act of 2018 (H.R. 6756).
Press Release | September 14, 2018
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) announced that Vernon R. Loucks, Jr., former chairman and CEO of Baxter International, will receive the 2018 AdvaMed Lifetime Achievement Award at the industry’s premier annual gathering – The MedTech Conference – Sept. 25 in Philadelphia.
Events
September
24
September 24, 2018 to September 26, 2018
| Philadelphia, PA The MedTech Conference is your opportunity to connect with thousands of medical technology professionals in one place, at one time.
Join us in Philadelphia for business development, innovative... Read More
October
15
October 15, 2018 to October 16, 2018
| Washington, DC FDA and industry experts are coming together to teach you the basics of 510(k) submissions.
This unique opportunity will help you better understand the FDA perspective on 510(k) submissions, from... Read More
October
17
October 17, 2018 | Virtual
We invite you to join a complimentary webinar that joins medical device industry experts with FDA quality leads to explain how device manufacturers can develop and improve quality culture.
Device... Read More
October
17
October 17, 2018 | Washington, DC
Join us in Washington, D.C. where FDA and industry experts will come together to lead you through the regulatory and practical guidelines governing when an investigational device exemption (IDE) is... Read More
October
18
October 18, 2018 to October 19, 2018
| Washington, DC Join us in Washington, D.C. where FDA and industry experts will come together to lead you through the strategic considerations and practical steps of filing a Premarket Approval. This unique... Read More
Featured Video
The medical technology industry is committed to safety, effectiveness and quality for all devices. Companies employ scientists, physicians, engineers, quality experts and other professionals to research and examine every aspect of a medical device to ensure that it performs as intended.
Industry News
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...
Helius Medical Technologies, Inc.
NEWTOWN, PA., April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions. The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology.
With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Twitter Feed
September 21, 2018 - 4:01pm
The Senate must ensure America remains the world leader in medical innovation. The Senate must repeal the medical d… https://t.co/8btiLTcSRm
September 21, 2018 - 2:01pm
This MedTech pain relief solution performs magnetic stimulation of brain structures and networks related to chronic… https://t.co/Fygsp3FHjF